ADMA Biologics Inc. (ADMA)

NASDAQ: ADMA · IEX Real-Time Price · USD
2.37
+0.14 (6.28%)
At close: Aug 12, 2022 4:00 PM
2.45
+0.08 (3.38%)
After-hours: Aug 12, 2022 7:59 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011
Revenue
80.9442.2229.3516.9922.7610.667.185.923.071.12
Upgrade
Revenue Growth (YoY)
91.72%43.85%72.79%-25.37%113.49%48.53%21.34%92.84%174.35%46.92%
Upgrade
Cost of Revenue
79.7761.2939.542.1929.166.364.313.742.020.67
Upgrade
Gross Profit
1.17-19.07-10.16-25.21-6.44.32.872.171.040.45
Upgrade
Selling, General & Admin
42.935.0525.9122.518.758.496.754.824.373.14
Upgrade
Research & Development
3.655.912.343.935.577.697.029.529.33.47
Upgrade
Other Operating Expenses
134.893.018.658.585.454.623.852.421.75
Upgrade
Operating Expenses
59.5545.8431.2735.0832.9121.6318.3818.1916.098.36
Upgrade
Operating Income
-58.37-64.91-41.42-60.29-39.31-17.33-15.51-16.02-15.04-7.91
Upgrade
Interest Expense / Income
13.0611.998.995.523.292.241.841.290.620.03
Upgrade
Other Expense / Income
0.22-1.15-2.14-0.071.16-0.050.610.06-0.13-0.02
Upgrade
Pretax Income
-71.65-75.75-48.28-65.74-43.76-19.52-17.97-17.36-15.53-7.92
Upgrade
Income Tax
0000000-0.550-0.62
Upgrade
Net Income
-71.65-75.75-48.28-65.74-43.76-19.52-17.97-16.81-15.53-7.3
Upgrade
Net Income Common
-71.65-75.75-48.28-65.74-43.76-19.52-17.97-16.81-15.53-7.3
Upgrade
Shares Outstanding (Basic)
140865445231210975
Upgrade
Shares Outstanding (Diluted)
140865445231210975
Upgrade
Shares Change
62.03%58.51%20.27%97.37%88.39%16.72%12.06%42.27%24.03%1391.31%
Upgrade
EPS (Basic)
-0.51-0.88-0.89-1.45-1.91-1.61-1.73-1.81-2.38-1.39
Upgrade
EPS (Diluted)
-0.51-0.88-0.89-1.45-1.91-1.61-1.73-1.81-2.38-1.39
Upgrade
Free Cash Flow Per Share
-0.90-1.33-1.47-1.43-1.75-1.51-1.48-1.83-1.70-1.33
Upgrade
Gross Margin
1.40%-45.20%-34.60%-148.40%-28.10%40.30%39.90%36.70%34.00%40.20%
Upgrade
Operating Margin
-72.10%-153.80%-141.10%-354.90%-172.70%-162.60%-216.10%-270.80%-490.40%-707.40%
Upgrade
Profit Margin
-88.50%-179.40%-164.50%-387.10%-192.30%-183.10%-250.40%-284.20%-506.20%-653.00%
Upgrade
Free Cash Flow Margin
-155.50%-271.70%-272.60%-381.40%-175.50%-172.10%-215.20%-287.90%-361.30%-628.10%
Upgrade
Effective Tax Rate
0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.18%0.00%7.80%
Upgrade
EBITDA
-53.1-59.82-36.03-56.77-37.78-16.81-15.66-15.83-14.7-7.71
Upgrade
EBITDA Margin
-65.60%-141.70%-122.80%-334.30%-166.00%-157.60%-218.10%-267.60%-479.20%-689.20%
Upgrade
Depreciation & Amortization
5.53.943.263.452.690.470.470.250.210.18
Upgrade
EBIT
-58.59-63.76-39.29-60.22-40.47-17.28-16.13-16.08-14.91-7.89
Upgrade
EBIT Margin
-72.40%-151.00%-133.90%-354.50%-177.80%-162.00%-224.70%-271.80%-486.00%-705.50%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).